样式: 排序: IF: - GO 导出 标记为已读
-
Issue Information Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-11-24
No abstract is available for this article.
-
Timely integration of palliative care into cancer care Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-11-24 Natasja Johanna Helen Raijmakers, Lia van Zuylen, Carl Johan Fürst
In this issue, we have a Special Supplement focusing on palliative care. Despite many advances in oncology, the number of people living with incurable cancer is increasing, and cancer is still one of the leading causes of death in the world. In 2020, nearly 10 million people died due to cancer, which is nearly one in six deaths word wide (WHO, n.d.-a). Patients with incurable cancer need palliative
-
Distress screening for patients with malignant diseases: Role in assuring psycho-oncological support Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-11-24 Norbert Schäffeler, Stephan Zipfel, Andreas Stengel
Dear Editor, In the recently published machine-learning study by Günther et al., nonperformed distress screening was identified as a central predictor for a lack of adequate psycho-oncological care. We too are convinced that distress screening is essential for the management of psycho-oncological care and would like to underline the authors' arguments with our findings. Our electronic screening (ePOS)
-
Patient preference attributes in eHealth interventions for cancer-related fatigue: A scoping review Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-11-16 Lian Beenhakker, Annemieke Witteveen, Kim A. E. Wijlens, Ester J. M. Siemerink, Marije L. van der Lee, Christina Bode, Sabine Siesling, Miriam M. R. Vollenbroek-Hutten
Cancer-related fatigue (CRF) is one of the most reported long-term effects breast cancer patients experience after diagnosis. Many interventions for CRF are effective, however, not for every individual. Therefore, intervention advice should be adjusted to patients' preferences and characteristics. Our aim was to develop an overview of eHealth interventions and their (preference sensitive) attributes
-
‘When I can ride my bike, I think, am I at all as sick as they say?’ An exploration of how men with advanced lung cancer form illness perceptions in everyday life Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-11-16 Jesper Larsen Maersk, Elizabeth Rosted, Line Lindahl-Jacobsen
The purpose of this study was to explore how men with advanced lung cancer form perceptions of their illness in everyday life and how this influences perceptions about rehabilitation.
-
The experience of female oncological patients and fertility preservation: A phenomenology study Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-11-10 Lara del Valle, Silvia Corchón, Josefa Palop, Jose María Rubio, Luis Celda
The aim of this study is to analyse the experience of fertility preservation among female oncological patients.
-
Eribulin for the treatment of advanced breast cancer: A prospective observational registry study Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-11-06 Laura Kenny, Mark Beresford, Ian Brown, Vivek Misra, Hartmut Kristeleit
Eribulin treatment improved overall survival with predictable toxicities in phase 3 trials of patients with previously treated, locally advanced/metastatic breast cancer. This study (NCT02443428) prospectively observed eribulin-treated patients in real-world clinical practice.
-
Efficacy of interdisciplinary rehabilitation in child cancer survivors: Impact on physical fitness, fatigue and body composition after 1-year follow-up Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-11-03 Ruth Van der Looven, Elise De Vos, Kristof Vandekerckhove, Ilse Coomans, Geneviève Laureys, Catharina Dhooge
Childhood cancer survivors experience reduced physical activity level, participation as well as health-related quality of life. This prospective, pre-/post-intervention and follow-up cohort study aims to determine the efficacy of an interdisciplinary rehabilitation on improving physical fitness, fatigue and body composition.
-
The psychological impact of COVID-19 among newly diagnosed patients with breast cancer when cancer care was returning to normal Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-28 Jie Li, Songying Zhu, Wei Gao
We aim to evaluate anxiety, depression and fear of cancer progression in newly diagnosed patients with breast cancer when cancer care was returning to normal after COVID-19 by comparing them with the pre-COVID patients and explore the association of worries about further cancer care and loneliness with them.
-
Patient experiences and views on pharmaceutical care during adjuvant endocrine therapy for breast cancer: A qualitative study Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-27 Selma En-nasery - de Heer, Vashti N. M. F. Tromp, Marjan J. Westerman, Inge Konings, Jan Jacob Beckeringh, Christel L. M. Boons, Lonneke Timmers, Jacqueline G. Hugtenburg
The use of adjuvant endocrine therapy (AET) after primary treatment of hormone receptor-positive breast cancer reduces the risk of recurrence and mortality. However, non-adherence is still common. Limited consideration has been given to how users deal with AET and the role of pharmaceutical care. Therefore, this study aims to obtain insight into the needs and wishes of women using AET regarding pharmaceutical
-
Extrinsic emotional regulation experienced by lung cancer patients and their family caregivers during progression-free survival Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-27 Hong Yao, Yajie Hou, Xinqian Zhang, Qianqian Zhang
Existing research has found that both lung cancer patients and their informal caregivers reported higher level of emotional distress and psychological maladjustment. However, limited attention has been afforded to collective emotional experiences in patient-caregiver dyad, especially during progression-free survival.
-
Cancer patients admitted in the emergency department: A single-centre observational study Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-26 Rafael Barbosa de Santis, Alberto Julius Alves Wainstein, Gustavo Carvalho Oliveira Gonçalves Machado, Fernando Augusto Vasconcellos Santos, Mariana Ramos Peixoto Melo, Ana Paula Drummond-Lage
This study aims to analyse patients' clinical profiles seen at an emergency unit of a public oncology reference hospital in Belo Horizonte, Brazil.
-
Fight against cancer in Italy: What patients, caregivers and healthy citizens think about care delivery from National Health System Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-26 Maria Silvia Cona, Anna Maria Mancuso, Antonio Russo, Selene Rota, Sheila Piva, Nicla La Verde
This survey aimed to analyse healthy citizens (HC), cancer patients and their caregivers (CP&CG) perception about cancer care among six different Italian regions.
-
The Clinical Frailty Scale can indicate prognosis and care requirements on discharge in oncology and haemato-oncology inpatients: A cohort study Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-26 Jenny Welford, Raigan Rafferty, Katherine Hunt, David Short, Louise Duncan, Ann Ward, Christine Rushton, Adam Todd, Smeera Nair, Thomas Hoather, Miranda Clarke, Lydia Dawes, Victoria Anderson, Anne Pelham, Hannah Lowe, Felicity Dewhurst, Alastair Greystoke
Routinely used performance status scales, assessing patients' suitability for cancer treatment, have limited ability to account for multimorbidity, frailty and cognition. The Clinical Frailty Scale (CFS) is a suggested alternative, but research detailing its use in oncology is limited. This study aims to evaluate if CFS is associated with prognosis and care needs on discharge in oncology inpatients
-
Socio-economic outcomes among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: Results of the 58LAE study Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-25 Melissa Barbati, Michal Kicinski, Stefan Suciu, Françoise Mazingue, Els Vandecruys, Geneviève Plat, Anne Uyttebroeck, Catherine Paillard, Marie-Françoise Dresse, Pauline Simon, Claire Pluchart, Odile Minckes, Alina Ferster, Claire Freycon, Frederic Millot, Jutte Van Der Werff ten Bosch, Christophe Chantrain, Robert Paulus, Gaetan de Schaetzen, Giovanna Rossi, Pierre Rohrlich, Yves Benoit, Caroline
The objective of this study is to evaluate the socio-economic outcomes of survivors of childhood acute lymphoblastic leukaemia (ALL).
-
New approach to implement cancer patient care: The valutazione percorso rete oncologica campana (ValPeROC)-experience from an Italian oncology network Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-25 Anna Crispo, Giorgia Rivieccio, Luca Cataldo, Sergio Coluccia, Assunta Luongo, Elisabetta Coppola, Maria Grimaldi, Concetta Montagnese, Flavia Nocerino, Davide D'Errico, Egidio Celentano, Rocco Saviano, Anna Bastone, Giovanni Baglio, Carmine De Angelis, Fortunato Ciardiello, Antonio Avallone, Antonino Cassata, Raffaele Costanzo, Alessandro Morabito, Paolo Maione, Cesare Gridelli, Silvio Cigolari, Anna
The primary goal of the Campania Oncology Network (ROC) was to reduce cancer delay and care fragmentation through the establishment of cancer-specific multidisciplinary oncologic groups (GOMs) and diagnostic and therapeutic assistance paths (PDTAs).
-
Supporting decision-making regarding fertility preservation in patients with cancer: An integrative review Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-24 Jeehee Han, Sangwoo Park, Sung Hae Kim
Recent reproductive technology for cancer patients has provided multiple options to preserve their fertility. Preserving fertility can increase quality of life of cancer patients. However, medical service providers and patients face difficulties in the decision-making process for the fertility preserving treatment because studies focusing on the concept of decision-making and various intervention materials
-
Relationships among sexual function, marital intimacy, type D personality and quality of life in patients with ovarian cancer, with spouses Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-24 Ju-Hee Nho, Sung Reul Kim, Won Ku Choi
This study aimed to identify the relationships among sexual function, marital intimacy, type D personality and quality of life (QoL) in patients with ovarian cancer, with spouses.
-
Pharmaceutical cancer care for haematology patients on oral anticancer drugs: Findings from an economic, clinical and organisational analysis Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-23 Jeremie Zerbit, Marie Kroemer, Basile Fuchs, Marion Detroit, Justine Decroocq, Marguerite Vignon, Lise Willems, Bénédicte Deau-Fischer, Patricia Franchi, Paul Deschamps, Adrien Contejean, Eric Grignano, Guillemette Fouquet, Rudy Birsen, Johanna Mondesir, Mathieu Rocquet, Jean-François Huon, Rui Batista, Jeanne Marty-Reboul, Didier Bouscary
The clinical benefit of pharmaceutical cares in improving the quality-of-care outcomes is well demonstrated. Clinical pharmacy services are not systematically deployed in cancer units in the absence of economic data. The aim of this prospective, observational 1-year study was to evaluate the clinical, economic and organisational impacts of pharmaceutical care into a multidisciplinary day hospital for
-
Exploring psychological resilience and demoralisation in prostate cancer survivors Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-21 Ching Hui Chien, See Tong Pang, Cheng Keng Chuang, Kuan Lin Liu, Chun Te Wu, Kai Jie Yu, Xuan Yi Huang, Po Hung Lin
This study aimed to investigate psychological resilience and demoralisation and their predictors and mediators in prostate cancer survivors (PCSs).
-
Developing a care pathway for hospital-based advance care planning for cancer patients: A modified Delphi study Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-21 Anna J. Pedrosa Carrasco, Pia Berlin, Liv Betker, Jorge Riera-Knorrenschild, Pia von Blanckenburg, Carola Seifart
The objective of this study is to develop a care pathway for a hospital-based advance care planning service for cancer patients.
-
Systematic adaptation of the adherence improving self-management strategy to support breast cancer survivors' adherence to adjuvant endocrine therapy: An intervention mapping approach Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-20 Anna M. Janssen, Joëlle Dam, Judith Prins, Laurien M. Buffart, Marijn de Bruin
Non-adherence to adjuvant endocrine therapy (AET) for breast cancer leads to increased recurrence and mortality risk and healthcare costs. Evidence on feasible, effective AET adherence interventions is scarce. This paper describes the systematic adaptation of the cost-effective adherence improving self-management strategy (AIMS) for patients with HIV to AET for women after breast cancer treatment.
-
Development and psychometric evaluation of a lymphoedema self-management behaviour questionnaire for breast cancer patients Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-19 Xiaoxia Wei, Qian Lu, Aomei Shen, Xin Fu, Lichuan Zhang, Yujie Wang, Yingxin Wang
The study was aimed to develop and evaluate a lymphoedema self-management behaviour questionnaire (LSMBQ) for breast cancer patients.
-
Stakeholders' perceptions of a community-based advanced nurse practitioner-led integrated oncology care model for adults receiving oral anti-cancer medication—A qualitative study Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-19 Janice Patricia Richmond, Alison Johnston, Mary Grace Kelly, Kevin Roche, Patrick J. Murphy, Andrew W. Murphy
Oral anti-cancer medications (OAMs) are increasingly prescribed in oncology, and although administered at home, ongoing monitoring generally requires the patient to attend an acute hospital. With the requirement to provide safe yet convenient care and to increase hospital capacity, the potential exists to transition this cohort of patients to the community to be assessed by oncology health care professionals
-
Fear of cancer recurrence and coping attitudes of breast cancer survivors Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-19 Bediye Oztas, Meltem Ugurlu, Gonul Kurt
This study aimed to determine the fear of cancer recurrence levels and coping orientation of breast cancer survivors.
-
Trajectories of symptom severity predicts quality of life change in newly diagnosis lymphoma survivors: An initial study Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-18 Chih-Jung Wu, Yu-Chi Chen, Li-Yuan Bai, Tzeon-Jye Chiou, Kuan-Chia Lin, Ya-Jung Wang
This study aimed to explore the subgroups of symptom severity and impact of their trajectories on quality of life in lymphoma survivors.
-
Systematic review of shared decision-making in guidelines about colorectal cancer screening Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-18 Marta Maes-Carballo, Manuel García-García, Yolanda Gómez-Fandiño, Carlos Roberto Estrada-López, Andrés Iglesias-Álvarez, Aurora Bueno-Cavanillas, Khalid Saeed Khan
We aimed to systematically evaluate quality of shared decision-making (SDM) in colorectal cancer (CRC) screening clinical practice guidelines (CPGs) and consensus statements (CSs).
-
‘It needs experience and courage’: Awareness towards end of life communication practices in oncologists: A mixed methods study Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-18 Tamara Diendorfer, Sophie Roider-Schur, Carola Lütgendorf-Caucig, Eva Katharina Masel, Herbert Watzke, Richard Pötter, Kathrin Kirchheiner
End of life communication (EOLC) is generally regarded as a challenging aspect of the medical profession, with high influences of culture, the physician's experience and awareness. The aim of the current study was to assess the awareness of Austrian oncologists towards EOLC practices in their daily clinical routine and to identify limiting and supporting factors of these conversations.
-
Adherence to adjuvant endocrine therapy among White British and ethnic minority breast cancer survivors in the United Kingdom Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-18 Serena McGuinness, Lyndsay Hughes, Rona Moss-Morris, Myra Hunter, Sam Norton, Zoe Moon
Around half of women do not take adjuvant endocrine therapy (AET) as prescribed. Research suggests that adherence rates vary across ethnic groups. This study compared AET adherences rates in White British women and women from minority ethnic groups in the United Kingdom.
-
Physical functioning and physical activity after gastrointestinal or bladder oncological surgery: An observational cohort study Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-17 Petra Bor, Marijke Elizabeth de Leeuwerk, Karin Valkenet, Richard van Hillegersberg, Cindy Veenhof
The aim of this study was to investigate the recovery of physical functioning and objective physical activity levels up to 3 months after oncological surgery and to determine the association between physical activity levels and the recovery of physical functioning.
-
Life engagement and anxiety-depressive symptoms in adolescents and young adults with or without a cancer history and their mothers: A dyadic analytic approach Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-17 Fabienne Lemétayer, Manon Florquin, Pascal Chastagner, Jean-Baptiste Lanfranchi
The aim of the present study was to examine the dyadic relationships between symptoms of anxiety and depression and life engagement in mother-adolescent and young adult (AYA) dyads with and without a history of cancer.
-
Mastication in health-related quality of life in patients treated for oral cancer: A systematic review Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-14 Jorine A. Vermaire, Abbergayle S. K. Partoredjo, Reilly J. de Groot, Henk S. Brand, Caroline M. Speksnijder
Treatment for oral cancer can impair oral functions such as mastication, which may negatively affect quality of life (QoL). In this review, an overview is provided of masticatory ability in patients treated for oral cancer.
-
Cost-effectiveness analysis of primary treatments for localised prostate cancer: A population-based Markov analysis using real-world evidence Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-14 Xiuhua Weng, Lixian Zhong, Pin Xiang, Yiyuan Li, Alan Paciorek, Liangliang Dong, Jeanette Broering, Peter R. Carroll, Martin Sanda, Leslie Wilson
We evaluate cost-effectiveness of primary treatments for localised prostate cancer by uniquely combining prospectively collected real-world outcomes and costs from UCSF Cancer of Prostate Strategic Urologic Research Endeavor (CaPSURE™).
-
Effect of chewing gum on the management of chemotherapy-induced oral mucositis in children: Systematic review of experimental studies Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-14 Remziye Semerci, Esra Nur Kocaaslan
It was aimed to systematically synthesise the available literature on examining the effect of chewing gum in the management/reduction of chemotherapy-induced oral mucositis in children.
-
Information needs and research priorities in long-term survivorship of breast cancer: Patients and health professionals' perspectives Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-13 Beatriz León-Salas, Yolanda Álvarez-Pérez, Vanesa Ramos-García, Mª. del Mar Trujillo-Martín, Ana María de Pascual y Medina, Magdalena Esteva, Noé Brito-García, Nerea González-Hernández, Uriel Bohn-Sarmiento, M. Concepción Biurrun-Martínez, Pedro Serrano-Aguilar
The objective of this work is to identify unmet information needs of long-term-survivors of breast cancer (BC) and future research needs from the perspectives of patients and health care professionals.
-
The impacts of unmet supportive care needs of cancer survivors in Australia: A qualitative systematic review Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-12 Olivia Bellas, Emma Kemp, Laura Edney, Candice Oster, Jackie Roseleur
Cancer incidence and survivorship are increasing worldwide. With more people living through and beyond cancer, there is a subsequent increase in their supportive care needs. This systematic review of qualitative studies aimed to describe the impacts of unmet supportive care needs on cancer survivors in Australia.
-
Diagnosis, management and impact on patients' lives of cancer-related neuropathic pain (CRNP): A European survey Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-12 Denis Dupoiron, Silviu Brill, Corien Eeltink, Begoña Barragán, Dany Bell, Gudula Petersen, Mariëlle Eerdekens, Deirdre Ryan, Martin Rakuša
This study assessed the impact of cancer-related neuropathic pain (CRNP) on patients and the importance of the patient–healthcare professional (HCP) relationship in diagnosis and management.
-
Controlled non-randomised before–after study evaluating the impact of a focused recommendation card on vaccination rates of oncological patients—The Easy Vaccination in Oncology (EVO) strategy Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-11 Til R. Kiderlen, Katrin Trostdorf, Nicola Delmastro, Arne Salomon, Christian W. Scholz, Ernst Späth-Schwalbe, Veit Mansmann, Stephanie Roll, Mark Reinwald, Maike de Wit
By implementing a focused must-have vaccination strategy (Easy Vaccination in Oncology [EVO]), we aimed to increase rates for high-impact vaccinations (Streptococcus pneumoniae, influenza, herpes zoster and hepatitis B) in the at-risk population of oncological patients.
-
Perception about palliative care and factors influencing the likelihood of palliative care service utilisation among adult cancer patients in Ethiopia Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-11 Miheret Fikre Teklemariam, Mesfin Addise, Gashaye Asrat, Zenawi Hagos Gufue
This study aims to assess the perception about palliative care and factors influencing the likelihood of palliative care service utilisation among adult cancer patients in Tikur Anbessa Specialized Hospital, Ethiopia, 2019.
-
Users' perspective on rehabilitation interventions for young adult cancer survivors: A group concept mapping study Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-11 Maria Aagesen, Marc Sampedro Pilegaard, May Aasebø Hauken, Eva Elisabet Ejlersen Wæhrens, Karen la Cour
We aim to identify and prioritise rehabilitation interventions to strengthen participation in everyday life for young adult cancer survivors (YACS) between 18 and 39 years, involving the perspectives of YACS and relevant stakeholders.
-
Development, implementation and formative evaluation of a motivational-volitional intervention to promote sustainable physical activity in breast cancer survivors Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-11 Leonie Adams, Janine Feicke, Tobias Eckert, Rebecca Pikkemaat, Ulrike Spörhase, Eva-Maria Bitzer, Wiebke Göhner
The aim of the current project was the development, implementation and evaluation of the programme, Motivational-Volitional Intervention-Movement After Breast Cancer (Mo-Vo-BnB), an intervention for the sustainable promotion of physical activity of breast cancer survivors.
-
Quality of life of family caregivers and survival of head and neck cancer patients in palliative care Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-10 Daniel Paixão Pequeno, Juliana Carron, Karla Cristina Gaspar, Carmen Silvia Passos Lima, Gustavo Jacob Lourenço
The aim of this study is to assess the effect of sociodemographic and genetic features on the quality of life (QoL) of family caregivers (FCGs) of patients with head and neck cancer (HNC) in palliative care (PC) and the effect of QoL of FCGs on patients' survival.
-
Adherence to adjuvant hormonal therapy in localised breast cancer Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-07 Steven Davies, Ioannis A. Voutsadakis
Hormonal therapies are the cornerstone of systemic adjuvant treatment of oestrogen receptor (ER) positive breast cancer. The full benefit of this treatment is obtained with long-term adherence. However, discontinuation of hormonal therapy is common. Factors associated with non-compliance to therapy are complex and worth of detailed evaluation.
-
Understanding pain related to adjuvant endocrine therapy after breast cancer: A qualitative report Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-04 Emily A. Walsh, Reena Chabria, Ana-Maria Vranceanu, Elyse R. Park, Kathryn Post, Jeffrey Peppercorn, Jennifer S. Temel, Joseph A. Greer, Jamie M. Jacobs
Most patients report pain while taking adjuvant endocrine therapy (AET) for the treatment of breast cancer. While studies have examined patients' experiences with side effects, none solely capture patients' experiences with AET-related pain, a troubling symptom that reduces quality of life and impairs treatment adherence. This study explored themes of AET-related pain to inform future intervention
-
The possibility of impossibility: The hope for a cure among terminally ill cancer patients in China Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-10-04 Xin Zhang, Bei Ju, Jiong Tu, Bo Wang, Xuan Liu, Zhechen Wang, Yu Cheng, Changhua Zhang, Yulong He
Although the medical potential of the hope for a cure has been fiercely debated within academia, few researchers have approached this topic from the perspective of terminally ill cancer patients themselves. As such, this article aims to help bridge the gap by exploring how terminally ill cancer patients in China construct the hope for a cure.
-
Optimising the management of patients with multiple myeloma in Spain: A measurement of the social return on investment Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-09-30 María Merino, Yoana Ivanova, Paulina Maravilla-Herrera, Begoña Barragán, Jordi Sierra, Ángeles Peñuelas-Saiz, Álvaro Hidalgo-Vega
The aim of this study was to reach a consensus on a set of proposals to optimise the disease management of Multiple myeloma (MM) within the Spanish National Health System (SNHS) and to apply the Social Return on Investment (SROI) method to estimate their social impact.
-
A qualitative exploration of the facilitators and barriers to early diagnosis and treatment of head and neck cancer: Perceptions of patients and carers Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-09-30 Rebecca L. Venchiarutti, Lily Pho, Jonathan R. Clark, Carsten E. Palme, Jane M. Young
The objective of this study to explore experiences of patients and carers of the pathway to diagnosis and treatment of head and neck cancer (HNC), focusing on differences based on remoteness of residence.
-
Hospitalisations of patients with cancer in the last stage of life. Reason to improve advance care planning? Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-09-29 Annemieke van der Padt-Pruijsten, Tanja Oostergo, Maria B. L. Leys, Carin C. D. van der Rijt, Agnes van der Heide
The aim of this study is to examine why patients are hospitalised in the last stage of life.
-
Rehabilitation in children and adolescents undergoing stem cell transplantation: A pilot study focused on motor performance Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-09-28 Francesca Rossi, Giulia Zucchetti, Maria Esposito, Paola Berchialla, Veronica Sciannameo, Elena Vassallo, Francesco Saglio, Carolina Chamorro Viña, Silvia Scarrone, Roberta Vittorini, Franca Fagioli
The aim of this pilot trial is evaluating the preliminary effectiveness of two in-hospital interventions in the maintenance of motor performance in children/adolescents undergoing hematopoietic stem cell transplantation (HSCT). Secondary objectives investigated the interventions' feasibility, impact on fatigue and to what degree the subjects' maintained their ankle dorsiflexion range of movement (ROM)
-
Palliative care facilitates the preparedness of caregivers for thoracic cancer patients Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-09-28 Nienke Zomerdijk, Stacey Panozzo, Linda Mileshkin, Jaclyn Yoong, Anna K. Nowak, Martin R. Stockler, Jennifer Philip
Palliative care improves outcomes for patients with thoracic cancer; however, limited evidence exists for the benefits of this approach for caregivers. This study aimed to advance understanding of the experiences of palliative care described by bereaved caregivers.
-
Exploring the validity of the body image scale with survivors of breast cancer: A cognitive interview approach Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-09-27 Corrie Effa, Mona M. Al Onazi, Nancy Spencer, Lesley Pritchard, Ian Fletcher, Margaret L. McNeely
The aim of this study is to explore the construct validity of the Body Image Scale for Cancer Questionnaire (BIS) using cognitive interviews.
-
The Ambulatory Medical Assistance (AMA) programme during active-phase treatment in patients with haematological malignancies: A cost-effectiveness analysis Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-09-27 Anne-Sophie Michallet, Stephanie Malartre, Elodie Vignaud, Alexiane Bocquet, Pascale Sontag, Christelle Galvez, Jean-Yves Blay, Pierre Heudel, Alexandre Vimont, Martin Blachier, Marie Ferrua, Etienne Minvielle, Olivier Mir
The need for patient navigator is growing, and there is a lack of cost evaluation, especially during survivorship.
-
How can advance care planning support hope in patients with advanced cancer and their families: A qualitative study as part of the international ACTION trial Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-09-27 Hana Kodba-Čeh, Urška Lunder, Francesco Bulli, Glenys Caswell, Johannes J. M. van Delden, Marijke C. Kars, Ida J. Korfage, Guido Miccinesi, Judith A. C. Rietjens, Jane Seymour, Alessandro Toccafondi, Marieke Zwakman, Kristian Pollock
Clinicians' fears of taking away patients' hope is one of the barriers to advance care planning (ACP). Research on how ACP supports hope is scarce. We have taken up the challenge to specify ways in which ACP conversations may potentially support hope.
-
Work resumption and retention in patients with advanced cancer: Experiences and perspectives of general and occupational health care professionals Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-09-27 Amber D. Zegers, Emma S. van Andel, Donna C. E. Beerda, Desiree J. S. Dona, Eline J. Aukema, Linda Brom, Saskia F. A. Duijts
The objectives of this study were to explore the experiences and perspectives of general and occupational health care professionals regarding work resumption and work retention of patients with advanced cancer, and to identify barriers and facilitators these professionals may encounter.
-
The effect of music on pain and anxiety in patients receiving chemotherapy during COVID-19 Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-09-27 Gülsüm Yetiş Koca, Rukuye Aylaz
This research has been conducted to determine the effect of music on pain and anxiety levels of patients receiving chemotherapy during COVID-19.
-
Assessment of patient symptom burden and information needs helps tailoring palliative care consultations: An observational study Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-09-24 Mary-Joanne Verhoef, Boudewijn Sweep, Ellen J.M. de Nijs, Anne C. Valkenburg, Nanda Horeweg, Arwen H. Pieterse, Jenny T. van der Steen, Yvette M. van der Linden
The objective of this study is to study (1) the relationship between patient-reported symptom burden and information needs in hospital-based palliative care and (2) differences in patient-reported needs during the disease trajectory.
-
Self-efficacy in managing post-treatment care among oral and oropharyngeal cancer survivors Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-09-24 Sharon L. Manne, Shawna V. Hudson, Deborah A. Kashy, Matin Imanguli, Morgan Pesanelli, Sara Frederick, Janet Van Cleave
Physical and psychosocial effects of oral cancer result in long-term self-management needs. Little attention has been paid to survivors' self-efficacy in managing their care. Study goals were to characterise self-care self-efficacy and evaluate socio-demographics, disease, attitudinal factors and psychological correlates of self-efficacy and engagement in head and neck self-exams.
-
Patient attitudes towards changes in colorectal cancer surveillance: An application of the Health Belief Model Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-09-24 Maddison Dix, Carlene J. Wilson, Ingrid H. Flight, Molla M. Wassie, Graeme P. Young, Charles Cock, Sarah Cohen-Woods, Erin L. Symonds
This is to determine whether health beliefs regarding colorectal cancer (CRC) screening could predict discomfort with a change to CRC surveillance proposing regular faecal immunochemical tests (FIT) instead of colonoscopy.
-
Long-COVID and long-term cancer survivorship—Shared lessons and opportunities Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-09-24 Taku Harada, Kathryn Schmitz, Charles W. Helsper, Grace Campbell, Larissa Nekhlyudov
As of 2022, close to 90 million persons in the United States, 243 million persons in Europe and 585 million worldwide have been infected with the novel SARS-CoV-2 (COVID-19) virus and survived. Estimates vary but suggest that up to 50% may experience long-term sequelae, termed ‘Long-COVID’. While Long-COVID is a new condition, the phenomenon of disabling long-term effects following an illness requiring
-
Social ecological influences on treatment decision-making in men diagnosed with low risk, localised prostate cancer Eur. J. Cancer Care (IF 2.1) Pub Date : 2022-09-22 Megan McIntosh, Melissa J. Opozda, Camille E. Short, Daniel A. Galvão, Rebecca Tutino, Michael Diefenbach, Behfar Ehdaie, Christian Nelson
Individuals diagnosed with low risk, localised prostate cancer (PCa) face a difficult decision between active surveillance (AS) and definitive treatment. We aimed to explore perceived influences on treatment decision-making from the patient and partner's perspectives.